carbostyril has been researched along with Infection, Mycobacterium avium-intracellulare in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 9 (81.82) | 18.2507 |
2000's | 2 (18.18) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Asakura, K; Eguchi, K; Hasegawa, N; Horinouchi, H; Ishizaka, A; Izumi, Y; Kawamura, M; Kobayashi, K; Watanabe, M | 1 |
Kobashi, Y; Miyashita, N; Niki, Y; Oka, M; Yoshida, K | 1 |
Dekio, S; Hidaka, T; Kawahara, S; Saito, H; Sato, K; Tomioka, H | 1 |
Heilmann, HD; Sirgel, FA; Venter, A | 1 |
Bermudez, LE; Inderlied, CB; Young, LS | 1 |
Bollet, C; de Micco, P; Gevaudan, MJ; Mallet, MN | 2 |
Barbara-Burnham, L; Bermudez, LE; Inderlied, CB; Kolonoski, P; Wu, M; Young, LS | 1 |
Düzgüneş, N; Flasher, D; Gangadharam, PR; Luna-Herrera, J; Reddy, MV | 1 |
Barbeau, P; Lapeyre, C; Leng, B; Maugein, J; Pellegrin, I; Pellegrin, JL | 1 |
Bollet, C; de Lamballerie, X; de Micco, P; Gevaudan, MJ; Mallet, MN; Sambuc, R | 1 |
1 trial(s) available for carbostyril and Infection, Mycobacterium avium-intracellulare
Article | Year |
---|---|
Relationship between clinical efficacy of treatment of pulmonary Mycobacterium avium complex disease and drug-sensitivity testing of Mycobacterium avium complex isolates.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Clarithromycin; Drug Therapy, Combination; Female; Humans; Lung Diseases; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Quinolones; Radiography; Treatment Outcome | 2006 |
10 other study(ies) available for carbostyril and Infection, Mycobacterium avium-intracellulare
Article | Year |
---|---|
Early pulmonary resection for Mycobacterium avium complex lung disease treated with macrolides and quinolones.
Topics: Adult; Aged; Anti-Bacterial Agents; Antitubercular Agents; Bronchiectasis; Case Management; Clarithromycin; Combined Modality Therapy; Drug Resistance, Multiple, Bacterial; Female; Follow-Up Studies; Humans; Macrolides; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Pneumonectomy; Quinolones; Sputum; Thoracoplasty; Time Factors; Treatment Outcome | 2006 |
Therapeutic effect of KRM-1648 with various antimicrobials against Mycobacterium avium complex infection in mice.
Topics: Animals; Antitubercular Agents; Clarithromycin; Clofazimine; Drug Synergism; Drug Therapy, Combination; Ethambutol; Fluoroquinolones; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mycobacterium avium-intracellulare Infection; Ofloxacin; Quinolones; Rifamycins; Streptomycin | 1995 |
Comparative in-vitro activity of Bay y 3118, a new quinolone, and ciprofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex.
Topics: Anti-Infective Agents; Ciprofloxacin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Mycobacterium tuberculosis; Quinolones; Sputum; Tuberculosis, Pulmonary | 1995 |
Rifabutin and sparfloxacin but not azithromycin inhibit binding of Mycobacterium avium complex to HT-29 intestinal mucosal cells.
Topics: Anti-Infective Agents; Azithromycin; Bacterial Adhesion; Fluoroquinolones; Humans; Intestinal Mucosa; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Quinolones; Rifabutin; Tumor Cells, Cultured | 1994 |
In-vitro evaluation of clarithromycin, temafloxacin, and ethambutol in combination against Mycobacterium avium complex.
Topics: Acquired Immunodeficiency Syndrome; Anti-Infective Agents; Clarithromycin; Drug Synergism; Drug Therapy, Combination; Ethambutol; Evaluation Studies as Topic; Fluoroquinolones; Humans; Macrophages; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Quinolones | 1993 |
Activities of bay Y 3118, levofloxacin, and ofloxacin alone or in combination with ethambutol against Mycobacterium avium complex in vitro, in human macrophages, and in beige mice.
Topics: Animals; Anti-Infective Agents; Cell Line; Drug Combinations; Ethambutol; Female; Fluoroquinolones; Humans; Levofloxacin; Macrophages; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Ofloxacin; Quinolones; Rats | 1996 |
Treatment of intracellular Mycobacterium avium complex infection by free and liposome-encapsulated sparfloxacin.
Topics: Animals; Anti-Infective Agents; Cell Line; Cell Survival; Fluoroquinolones; Humans; Indicators and Reagents; Liposomes; Macrophages; Mice; Mice, Inbred Strains; Mycobacterium avium-intracellulare Infection; Quinolones | 1996 |
Activity of rifabutin, clarithromycin, ethambutol, sparfloxacin and amikacin, alone and in combination, against Mycobacterium avium complex in human macrophages.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Antitubercular Agents; Clarithromycin; Drug Therapy, Combination; Ethambutol; Fluoroquinolones; Humans; Macrophages; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Quinolones; Rifabutin | 1996 |
[Extracellular and intracellular activity of sparfloxacin against Mycobacterium avium complex and Mycobacterium xenopi].
Topics: Acquired Immunodeficiency Syndrome; Antitubercular Agents; Drug Synergism; Drug Therapy, Combination; Ethambutol; Fluoroquinolones; Humans; In Vitro Techniques; Mycobacterium; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections; Opportunistic Infections; Quinolones; Rifabutin; Rifamycins | 1992 |
[Activity of antibiotics against pigmented and unpigmented variants of Mycobacterium avium-intracellulare].
Topics: Acquired Immunodeficiency Syndrome; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; In Vitro Techniques; Lactams, Macrocyclic; Macrolides; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Opportunistic Infections; Quinolones | 1991 |